Skip to main content
Michael Steinberg, MD, Radiation Oncology, Los Angeles, CA

Michael Lee Steinberg MD


Professor of Radiation Oncology, UCLA-David Geffen School of Medicine

Join to View Full Profile
  • 200 Medical Plaza, Suite B265Los Angeles, CA 90095

  • Phone+1 310-825-9771

  • Fax+1 310-825-9771

Dr. Steinberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 1978 - 1981
  • University of Southern California/LACUSC Medical Center
    University of Southern California/LACUSC Medical CenterInternship, Transitional Year, 1976 - 1977
  • Keck School of Medicine of the University of Southern California
    Keck School of Medicine of the University of Southern CaliforniaClass of 1976

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1977 - 2026
  • NV State Medical License
    NV State Medical License 1981 - 2009
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • MRI-Guided Radiotherapy for Head and Neck Cancer: Initial Clinical Experience  
    M Cao, S Hsu, Y Yang, M L Steinberg, A M Chen, J Lamb, Clinical & translational oncology

Press Mentions

  • Test Predicts Which Patients with Prostate Cancer Most Likely to Develop Long-Term Side Effects from Radiation Therapy
    Test Predicts Which Patients with Prostate Cancer Most Likely to Develop Long-Term Side Effects from Radiation TherapyApril 7th, 2025
  • Study Confirms Safety and Efficacy of Higher-Dose-Per-Day Radiation for Early-Stage Prostate Cancer
    Study Confirms Safety and Efficacy of Higher-Dose-Per-Day Radiation for Early-Stage Prostate CancerMarch 18th, 2025
  • {HMN 2025}: The Study Establishes a Hyperlink Between Early Unwanted Effects from Prostate Cancer Radiation and Long-Term Unwanted Effects
    {HMN 2025}: The Study Establishes a Hyperlink Between Early Unwanted Effects from Prostate Cancer Radiation and Long-Term Unwanted EffectsFebruary 5th, 2025
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: